Skip to main content

ACETAZOLAMIDE

NDC 59651-906 · Aurobindo Pharma Limited

Generic nameACETAZOLAMIDE
Dosage formTABLET
RouteORAL
Active ingredient(s)ACETAZOLAMIDE
Strength250 mg/1
Pharmacologic classCarbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
Marketing categoryANDA

Packages

59651-906-01 — 100 TABLET in 1 BOTTLE (59651-906-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50090-5617 — acetazolamide, 50090-5945 — Acetazolamide, 50090-7536 — acetaZOLAMIDE, 50268-042 — Acetazolamide Extended-Release, 50268-054 — Acetazolamide, 50742-233 — Acetazolamide, 51655-331 — acetazolamide, 52817-200 — ACETAZOLAMIDE, 52817-201 — ACETAZOLAMIDE, 59651-905 — ACETAZOLAMIDE, 60687-578 — acetazolamide, 62135-607 — Acetazolamide, 62135-608 — Acetazolamide, 62135-612 — Acetazolamide, 62332-349 — Acetazolamide, 63629-1194 — Acetazolamide, 63629-1195 — Acetazolamide, 64380-833 — Acetazolamide, 64380-834 — Acetazolamide, 65841-762 — acetazolamide, +44 more

Poisoning, adverse-effect and underdosing codes for this drug

The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.

T50.2X1 — Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unintentional), T50.2X2 — Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm, T50.2X3 — Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, assault, T50.2X4 — Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined, T50.2X5 — Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, T50.2X6 — Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics